Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing

Wendy Cheng, Stuart Roberts, Geoffrey McCaughan, William Sievert, Martin Weltman, Darrell Crawford, William Rawlinson, Phillipa Marks, James Thommes, Bishoy Rizkalla, Motoko Yoshihara, Gregory Dore

Research output: Contribution to journalArticleResearchpeer-review

45 Citations (Scopus)

Abstract

The impact of fibrosis stage on chronic hepatitis C virus (HCV) treatment response was explored in CHARIOT, a study of high dose peginterferon alfa-2a (PEG-IFNalpha-2a) induction therapy in treatment na??ve genotype 1 infection.
Original languageEnglish
Pages (from-to)616 - 623
Number of pages8
JournalJournal of Hepatology
Volume53
Issue number4
DOIs
Publication statusPublished - 2010

Cite this